Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKinsey
Johnson and Johnson
Argus Health
Cantor Fitzgerald
Boehringer Ingelheim
Federal Trade Commission
Cerilliant
US Army

Generated: June 20, 2018

DrugPatentWatch Database Preview

INCRELEX Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Increlex, and what generic alternatives are available?

Increlex is a drug marketed by Ipsen Inc and is included in one NDA.

The generic ingredient in INCRELEX is mecasermin recombinant. One supplier is listed for this compound. Additional details are available on the mecasermin recombinant profile page.
Summary for INCRELEX
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Clinical Trials: 14
DailyMed Link:INCRELEX at DailyMed
Drug patent expirations by year for INCRELEX

US Patents and Regulatory Information for INCRELEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ipsen Inc INCRELEX mecasermin recombinant INJECTABLE;SUBCUTANEOUS 021839-001 Aug 30, 2005 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for INCRELEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ipsen Inc INCRELEX mecasermin recombinant INJECTABLE;SUBCUTANEOUS 021839-001 Aug 30, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Ipsen Inc INCRELEX mecasermin recombinant INJECTABLE;SUBCUTANEOUS 021839-001 Aug 30, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Ipsen Inc INCRELEX mecasermin recombinant INJECTABLE;SUBCUTANEOUS 021839-001 Aug 30, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Deloitte
Johnson and Johnson
Express Scripts
QuintilesIMS
Chinese Patent Office
Harvard Business School
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.